- Home
- DSGX vs LNTH Comparison
DSGX vs LNTH Comparison
Compare DSGX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- LNTH
- Stock Information
- Founded
- DSGX 1981
- LNTH 1956
- Country
- DSGX Canada
- LNTH United States
- Employees
- DSGX N/A
- LNTH N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DSGX Technology
- LNTH Health Care
- Exchange
- DSGX Nasdaq
- LNTH Nasdaq
- Market Cap
- DSGX 8.8B
- LNTH 7.5B
- IPO Year
- DSGX 1999
- LNTH 2015
- Fundamental
- Price
- DSGX $105.55
- LNTH $101.77
- Analyst Decision
- DSGX Buy
- LNTH Strong Buy
- Analyst Count
- DSGX 12
- LNTH 6
- Target Price
- DSGX $117.42
- LNTH $129.83
- AVG Volume (30 Days)
- DSGX 317.7K
- LNTH 814.4K
- Earning Date
- DSGX 05-28-2025
- LNTH 05-07-2025
- Dividend Yield
- DSGX N/A
- LNTH N/A
- EPS Growth
- DSGX 22.39
- LNTH N/A
- EPS
- DSGX 1.64
- LNTH 4.36
- Revenue
- DSGX $651,000,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- DSGX $11.87
- LNTH $5.74
- Revenue Next Year
- DSGX $13.36
- LNTH $12.27
- P/E Ratio
- DSGX $61.07
- LNTH $23.34
- Revenue Growth
- DSGX 13.63
- LNTH 18.32
- 52 Week Low
- DSGX $89.00
- LNTH $65.09
- 52 Week High
- DSGX $124.31
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- DSGX 56.59
- LNTH 54.82
- Support Level
- DSGX $99.33
- LNTH $97.43
- Resistance Level
- DSGX $103.80
- LNTH $104.04
- Average True Range (ATR)
- DSGX 3.53
- LNTH 5.25
- MACD
- DSGX 0.81
- LNTH 0.20
- Stochastic Oscillator
- DSGX 95.09
- LNTH 88.08
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.